Companies: 10,795·Total market cap: $144.5T
Cyclacel Pharmaceuticals, Inc.

Cyclacel Pharmaceuticals, Inc.

CYCCNASDAQHealthcare
$6.37
$-0.41(-5.98%)
Market Cap$10608329
P/E Ratio—
52W High$597.59973
52W Low$3.0801
Overview

Cyclacel Pharmaceuticals, Inc. (CYCC) Stock Splits

Forward and reverse split history, cumulative multiple, latest ratio, and share calculator on this tab.

FMP · CYCC · as of Sep 11, 2025

Key split metrics

Total Splits7Since IPO (Mar 16, 2004)
Most Recent SplitJul 7, 2025Reverse · 1-for-15
Cumulative Multiple×0.00001 share (2004) → 0.0000 shares today

Latest Split Event

Reverse Split
Jul 7, 2025
BEFORE SPLIT$0.2400Closing price · Jul 3, 2025
1-for-15
AFTER SPLIT$3.91Opening price · Jul 7, 2025
Every 15 shares were consolidated into 1 share.·Total market cap unchanged.·Source: FMP · Historical EOD

Stock Split History

CYCC · 7 records
Date↓RatioTypeMultiple↕Cumulative↕
Jul 7, 20251-for-15Reverse×0.067×0.00e+0
May 12, 20251-for-16Reverse×0.063×0.00e+0
Dec 18, 20231-for-15Reverse×0.067×0.00e+0
Apr 15, 20201-for-20Reverse×0.050×0.000100
May 31, 20161-for-12Reverse×0.083×0.001
Aug 27, 20121-for-7Reverse×0.143×0.014
Mar 27, 20061-for-10Reverse×0.100×0.100
7 splits since IPO · Mar 16, 2004Data: Financial Modeling Prep · Updated daily

Stock Split Calculator

If you bought 100 shares purchased of CYCC on Jan 1, 2020 — — how many shares would you hold today after all splits?

ORIGINAL SHARES100
→
SHARES TODAY0.0014
Splits Applied4
Total Multiplier×0.00
Split Period2020–2025
Splits applied:Apr 15, 2020 · 1-for-20Dec 18, 2023 · 1-for-15May 12, 2025 · 1-for-16Jul 7, 2025 · 1-for-15
Based on purchase date Jan 1, 2020Share count only · excludes price / dividendsSource: FMP

This calculator shows how stock splits affected share count only. It does not reflect current market value, dividend payments, or transaction costs. Past splits do not guarantee future performance.

About reverse stock split history

Cyclacel Pharmaceuticals, Inc. (CYCC) has undergone 7 reverse stock splits. The most recent was a 1-for-15 reverse split on Jul 7, 2025. Reverse splits consolidate shares to increase the per-share price.

Price historyShares outstandingFinancialsEarningsMarket capForecast

Frequently asked questions

Cyclacel Pharmaceuticals, Inc. (CYCC) has undergone 7 reverse stock splits. Reverse splits consolidate shares, reducing share count while increasing the per-share price.

CYCC reverse stock split historyhow many reverse splits for CYCCCYCC stock split countcumulative split multiple
Data: Financial Modeling Prep · Updated daily · For informational purposes only, not investment advice.